About Us
About Us
What we stand for
Governance
External Advisory Board
Transversal Units
Our Heritage
Contacts
Research
Integrative Programs
Research Groups
Publications
Scientific Platforms
Responsible Research
Events
Seminars
Upcoming Events
Events Archive
Education
Advanced Training
Post-Graduations
i3S Community
About our Community
Postdoc Representatives
PhD Student Representatives
Postgraduate Student Ombudsperson
Honorary Researchers
People
Knowledge Translation
Clinical Initiatives
Innovation and Valorization
Science in Society
Jobs & Internships
Job Opportunities
Academic Internships
Legal & Funding
Status & Reports
Funding & Sponsoring
Market Consultation
Notices
Public Procurement
Transparency
News
PT
creating a
healthier future
DONATE NOW
SUPPORT SCIENCE
News Archive
18.12.18
i3S renews FELASA accreditation
IBMC/i3S runs the only FELASA-accredited course in Portugal since 2008.
18.12.10
Joint project to study TB
Project in Guinea-Bissau launched to study tuberculosis caused by the bacterium Mycobacterium africanum.
18.12.03
Young i3S researcher wins ESHG Fellowship
Ana Rita Matos gets her work acknowledged by the European Society of Human Genetics.
18.12.01
Salomé Pinho draws in more funding
Researcher receives award from international organization for a project in Inflammatory Bowel Disease.
18.11.15
Open positions at i3S
i3S opens international calls for 8 doctorate research positions. Applications welcome until November 29th.
18.11.08
MCbiology: 3rd call open
The doctoral program MCbiology has its third call for applications open until November 16th.
18.10.24
i3S project wins Pfizer Award
Pfizer Awards acknowledge Céu Figueiredo and her team.
18.10.02
i3S Call for new Research Groups
In this open international call, we are looking for junior/mid-career researchers from any nationality.
18.09.21
World’s most influential pathologist is i3S researcher
Fátima Carneiro, i3S researcher and Professor at FMUP, was voted the most influential pathologist in the world by her p...
Subscribe to our newsletter and keep up to date with our latest achievements.
Newsletter Subscription
Previous
1
2
3
4
5
6
7
8
9
...
45
Next
Back